New Study to Get More Minorities Involved in Genetic Testing
837 articles
New Clinical Accelerator Initiative Shortens Time from Bench to Clinic
Dr. Elizabeth Jaffee explains the importance of Lustgarten’s Clinical Accelerator Initiative to speed up the time from bench to trial.
Research: The Next Generation
AACR young researchers come from all over the world, and add their perspectives to pancreatic cancer studies.
Pancreatic Cancer Exceptional Responders and the Immune System Link
Dr. Vinod Balachandran looks at the immune system of exceptional responders–patients who respond extremely well to chemotherapy–for treatment clues.
MORE Magazine: The Cancer Campaign That Got Personal
After a diagnosis of stage IV pancreatic cancer, Anne Glauber turned to research to find a treatment that could extend her life.
Chemotherapy-Radiation Combination for Pancreatic Cancer in the Liver
Can targeted radiation disrupt tumor growth in the liver of advanced pancreatic cancer patients with BRCA2 and PALB2 mutations?
Using AI to Create a Better Test to Predict Pancreatic Cancer Progression
Dr. Dan Theodorescu is using AI to isolate more effective biomarkers than the CA 19-9 test to track pancreatic cancer progression.
The Link Between Pancreatic Cancer and Diabetes
Dr. Suresh Chari of the Mayo Clinic has spent a good part of his career looking at the relationship between pancreatic cancer and diabetes.
Two-Drug Combo Targets KRAS and Fights Resistance
Researcher Hervé Tiriac leads a clinical trial for a new drug combination targeting KRAS and chemotherapy resistance.